US 7956220
MAO-B inhibitors useful for treating obesity
granted A61PA61P25/16A61P25/18
Quick answer
US patent 7956220 (MAO-B inhibitors useful for treating obesity) held by Jenrin Discovery, LLC expires Mon Jun 02 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Jenrin Discovery, LLC
- Grant date
- Tue Jun 07 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 02 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P25/16, A61P25/18, A61P25/22, A61P25/24